ArticleJournal of the National Cancer Institute2025

Pan-cancer genomic analysis reveals FOXA1 amplification is associated with adverse outcomes in non-small cell lung, prostate, and breast cancers.

Alexander G Goglia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.